Up-regulation of the DR5 Expression by Proteasome Inhibitor MG132 Augments TRAIL-Induced Apoptosis in Soft Tissue Sarcoma Cell Lines
Cancer Research and Treatment. 2011;43(2):124-130 
p53-Independent up-regulation of a TRAIL receptor DR5 by proteasome inhibitors: A mechanism for proteasome inhibitor-enhanced TRAIL-induced apoptosis
Biochemical and Biophysical Research Communications. 2011;416(1-2):222-225
The Proteasome Inhibitor MG132 Sensitizes Lung Cancer Cells to TRAIL-induced Apoptosis by Inhibiting NF-κB Activation
Tuberculosis and Respiratory Diseases. 2008;65(6):476
Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis
FEBS Journal. 2008;275(8):1925-1936
Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPSdown-regulation
Journal of Cellular Biochemistry. 2008;105(6):1386-1398
Trail induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines
European Journal of Cancer. 2001;37:S111
The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5
Scientific Reports. 2017;7(1):
Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Burkitt's lymphoma cell lines
British Journal of Haematology. 2003;122(1):61-69
Caspase-8 dependent osteosarcoma cell apoptosis induced by proteasome inhibitor MG132
Cell Biology International. 2007;31(10):1136-1143
Triptolide sensitizes TRAIL-induced apoptosis in prostate cancer cells via p53-mediated DR5 up-regulation
Molecular Biology Reports. 2012;39(9):8763-8770